Clinical Trials in New York State

Showing 6481-6500 of 17,167 trials

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

NCT04599972

This is a 4-visit, multi-center, randomized, double-masked, vehicle-controlled study evaluating the safety and efficacy of CSF-1 in the temporary correction of presbyopia.

Presbyopia

Orasis Pharmaceuticals Ltd.304 participantsStarted Oct 2020

Chandler, Arizona, United States • Mesa, Arizona, United States • Phoenix, Arizona, United States +15 more locations

COMPLETEDPhase 186 miles

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

NCT03724916

The purpose of this study is to evaluate the safety and tolerability of TAK-079 in comparison with matching placebo, administered once every 3 weeks over a 12-week dosing period in participants with active SLE who are receiving stable background therapy for SLE.

Systemic Lupus ErythematosusLupus Erythematosus, Systemic

Millennium Pharmaceuticals, Inc.23 participantsStarted Nov 2018

Anniston, Alabama, United States • Birmingham, Alabama, United States • La Jolla, California, United States +16 more locations

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Find Trials by Condition in New York State

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility

Spiration Valves Against Standard Therapy

Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)

REDAPT Retrospective-Prospective Modular Stem Study

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA